- So we've each had our copious amount of coffee just before coming on, and I feel like it's appropriate to ask you based on the body of your work, what you had for breakfast. - Coffee. - Coffee.All right, well, you know, CEOs take note. You heard it from Marion Nestle herself. - I'm not a breakfast eater.- Oh my goodness. We're gonna have to come back to that 'cause that feels significant. Let's get started with, you know, the other news of the day, which is, you know, the final version of Secretary Kenned ...

Ozempic and other weight-loss drugs may be a promising solution to the growing problem of obesity, but they’ve got a surprising foe: fat activists. https://t.co/Y8Qi1GIZQr ...

Industry Trend - Weight-loss drugs like Ozempic are seen as a potential solution to obesity [1] Social Impact - Fat activists are posing a challenge to the use of weight-loss drugs [1]

Ozempic and other weight-loss drugs may be a promising solution to the growing problem of obesity, but they’ve got a surprising foe: fat activists. https://t.co/wdC7XHm73J ...

“Even if every person living with obesity took medicines, we couldn’t treat our way out of this crisis,” warns Lars Fruergaard Jørgensen. In a guest essay he argues that “the world must prioritise prevention” https://t.co/W27aUCTPmDIllustration: Dan Williams https://t.co/TW0zerNZjd ...

Ozempic and other weight-loss drugs may be a promising solution to the growing problem of obesity, but they’ve got a surprising foe: fat activists. https://t.co/U4SjywQpBC ...

Industry Trend - Weight-loss drugs like Ozempic are seen as a potential solution to obesity [1] Potential Challenges - Fat activists are posing a challenge to the widespread acceptance of weight-loss drugs [1]

One side believes it can help people overcome obesity; the other wants to shift the focus from changing their bodies to helping them live in themhttps://t.co/ZuLA3FFYH6 https://t.co/XRO020BPpk ...

“Even if every person living with obesity took medicines, we couldn’t treat our way out of this crisis,” warns Lars Fruergaard Jørgensen. In a guest essay he argues that “the world must prioritise prevention” https://t.co/B5FT3Y6igl ...

news uh that we've I guess been waiting for from Eli Liy. Got a look at the stock. Uh although we'll show you that Angelica Peeles that's here and joins us now, but uh as you're talking, we should take a quick look at the uh early morning action in the shares.But take it away. >> Yeah, that early morning action not good. The stock down about 6% right now and that's after we got this highly anticipated data on its obesity pill and clearly there's some disappointment.So let's go through the numbers. people lo ...